THE ATTEMPTED IN VIVO INHIBITION OF THE ORTHO-HYDROXYLATION OF 2-NAPHTHYLAMINE
1963

Inhibition of Ortho-Hydroxylation of 2-Naphthylamine

publication Evidence: moderate

Author Information

Author(s): F. Dewhurst

Primary Institution: Department of Cancer Research, Mount Vernon Hospital and the Radium Institute

Hypothesis

Can certain compounds inhibit the ortho-hydroxylation of 2-naphthylamine in vivo?

Conclusion

The study found that significant inhibition of the excretion of 2-amino-1-naphthol and its conjugates was observed with SKF-525-A and chlorpromazine, but not with riboflavin or other tested compounds.

Supporting Evidence

  • Significant inhibition of 2-amino-1-naphthol excretion was observed with SKF-525-A and chlorpromazine.
  • No inhibition was found with riboflavin, ascorbic acid, or other tested compounds.
  • 2-naphthylamine was rapidly excreted by the mice, indicating effective metabolism.

Takeaway

The researchers wanted to see if some medicines could stop a harmful process in mice, and they found a couple that worked, but many others did not.

Methodology

Mice were fed a diet containing 2-naphthylamine and injected with potential inhibitors, followed by urine collection to measure excretion of metabolites.

Limitations

The study did not explore long-term effects or the impact of other potential inhibitors not tested.

Participant Demographics

Strong A mice, 12-16 weeks old.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication